Sanofi-Aventis
Paris, France
NCT Number: NCT00633425
Analyse the glucose profile, based on continuous glucose monitoring by CGMS, in type 2 diabetics inadequately controlled by metformin, before and after the addition of Glimepiride.
Looking for future studies?
Notify Me35 year–70 year
All sexes
Interventional
Phase 4
Paris, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Time frame: The mean of 24 variations in average hourly glucose readings recorded by CGMS.
Time frame: Measured in the observation and maintenance phases, and change between the two phases.
Looking for future studies?
Notify MeSanofi
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02821117
Diabetes Mellitus, Endocrine System Diseases
Hanover, Germany
View Trial DetailsNCT05186389
Body Weight, Diabetes Mellitus
Paris, France
View Trial DetailsNCT02593032
Cardiovascular Diseases, Diabetes Mellitus
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT06186245
Acid-Base Imbalance, Acidosis
Lubbock, Texas, United States
View Trial Details